Skip to main content
NIST Author Manuscripts logoLink to NIST Author Manuscripts
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Anal Bioanal Chem. 2016 Apr 2;408(15):4179–4190. doi: 10.1007/s00216-016-9512-1

Development of a Multi-class Steroid Hormone Screening Method using Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS)

Ashley S P Boggs a, John A Bowden a, Thomas M Galligan b, Louis J Guillette Jr b, John R Kucklick a
PMCID: PMC4906791  NIHMSID: NIHMS790313  PMID: 27039201

Abstract

Monitoring complex endocrine pathways is often limited by indirect measurement or measurement of a single hormone class per analysis. There is a burgeoning need to develop specific direct-detection methods capable of providing simultaneous measurement of biologically relevant concentrations of multiple classes of hormones (estrogens, androgens, progestogens, and corticosteroids). The objectives of this study were to develop a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for multi-class steroid hormone detection using biologically relevant concentrations, then test limits of detection (LOD) in a high-background matrix by spiking charcoal-stripped fetal bovine serum (FBS) extract. Accuracy was tested with National Institute of Standards and Technology Standard Reference Materials (SRMs) with certified concentrations of cortisol, testosterone, and progesterone. 11-Deoxycorticosterone, 11-deoxycortisol, 17-hydroxypregnenolone, 17-hydroxyprogesterone, adrenosterone, androstenedione, cortisol, corticosterone, dehydroepiandrosterone, dihydrotestosterone, estradiol, estriol, estrone, equilin, pregnenolone, progesterone, and testosterone were also measured using isotopic dilution. Dansyl chloride (DC) derivatization was investigated maintaining the same method to improve and expedite estrogen analysis. Biologically relevant LODs were determined for 15 hormones. DC derivatization improved estrogen response two- to eight-fold, and improved chromatographic separation. All measurements had an accuracy ≤ 14 % difference from certified values (not accounting for uncertainty) and relative standard deviation ≤ 14 %. This method chromatographically separated and quantified biologically relevant concentrations of four hormone classes using highly specific fragmentation patterns and measured certified values of hormones that were previously split into three separate chromatographic methods.

Keywords: Steroid hormones, Liquid chromatography tandem mass spectrometry, Estrogens, Androgens, Progestogens, Corticosteroids

Introduction

The endocrine system controls signaling pathways that direct critical physiological processes such as development, reproduction, and metabolism [1]. A major group of signaling molecules of the endocrine system is the steroid hormone family. Steroid hormones are defined as endogenous hormones synthesized from a cholesterol backbone (a planar tetracyclic ring structure with rings usually denoted as A through D) and are enzymatically transformed into different classes of steroids (Figure 1) [1, 2]. Subtle changes in steroid structure (usually in number and location of carbonyl and hydroxyl functional groups) lead to drastic differences in physiological function [3]. There are four classes of steroid hormones, which include estrogens, androgens, progestogens, and corticosteroids. These classes are often grouped according to both structure and by which genomic receptors they bind to induce biological function [4]. Estrogens (18 carbons with an aromatic A ring) are typically denoted as female reproductive hormones, androgens (19 carbons) as male reproductive hormones, progestogens (21 carbons) as pregnancy hormones, and corticosteroids (21 carbons) as stress hormones [1]. Despite their categorization, steroid hormones have multiple functions that cross the general physiological categories, and are synthesized through a cascade-like pathway (meaning one hormone is required to produce the next) [4]. For example, while estrogens are thought of as “female hormones” and androgens thought of as “male hormones,” [3] almost all vertebrate males and females have detectable levels of both androgens and estrogens. Further, estrogens cannot be produced without first producing androgens. Cortisol, a corticosteroid typically associated with stress, has a reproductive function as it is associated with the initiation of labor and birth, whereas progestogens are often monitored for adrenal dysfunction. Because steroids have multiple physiological functions and a cascade-like synthesis pathway, studying hormone milieus would greatly enhance the knowledge of which steroid hormones are involved in key physiological functions. Additionally, most steroid hormones are present in all vertebrates, but different species regulate them at different concentrations. For example, dihydroprogesterone is the primary progestogen for pregnancy in elephants, whereas progesterone is the primary pregnancy hormone in humans [5]. By measuring only progesterone, the reproductive physiology of the elephant cannot be fully understood. However, a comprehensive steroid hormone profile could be used to understand the varying physiologies of species from fish to humans.

Fig. 1.

Fig. 1

Steroid hormone structures and synthesis pathways. Arrows represent enzymatic reactions between precursor and product steroids. Superscript letters represent hormone classification. P = progestogen, C = corticosteroid, A = androgen, E = estrogen. Equilin has an alternate synthesis pathway and is therefore displayed structurally, but not included in this synthesis pathway. Chemical structures are from PubChem.

The ability to monitor multiple alterations in hormone pathways is currently limited by the scope and scale of the traditional measurement methods typically used in biological studies. Radioimmunoassays (RIAs) and enzyme-linked immunosorbant assays (ELISAs) are the most commonly employed approaches for hormone measurement. These assays are generally extremely sensitive (capable of low pg/mL detections) due to the indirect, immunoglobulin-based measurement technologies that bind the hormone and amplify that signal through an enzymatic change or radioactive signal. However, the amplification technologies that give the immunoassays such sensitivity are often less reliable than direct quantification methods. Antibody cross-reactivity, matrix interferences, reliance on external calibration, and poor inter method reproducibility are all common issues due to the indirect detection methods of immunoassays [68]. Further, RIAs and ELISAs are designed for the explicit measurement of a single hormone per assay, thus limiting the ability to measure multiple hormones per sample.

While gas chromatography (GC) offers excellent chromatographic resolution and the benefit of multi-class profiling potential, the analysis of steroids using this method has its pitfalls. Many steroids have to be derivatized for GC-MS (mass spectrometry) which usually entails derivatizing the hydroxyl groups [9]. Reproducibility becomes an issue due to incomplete derivatization of compounds such as cortisol that have three hydroxyl groups. Therefore, the adoption of liquid chromatography (LC) separation using the underivatized compound remains more advantageous to GC-based methods.

Due to advances made in LC coupled with tandem mass spectrometry (MS/MS), LC-MS/MS methods are now preferred for the direct measurement of steroid hormones; however, this technique has its difficulties and many purported multi-class methods have limitations. Steroids have very similar structures and fragmentation patterns, making the separation of multiple steroids, some of which have identical masses, difficult yet critical. Additionally, many of the hormones that have been measured by LC-MS/MS did so by monitoring the precursor ion minus 18 amu [10], usually indicating a loss of water. The loss of water is a common fragmentation pattern not specific to hormones, which could lead to misidentifications in complex biological matrices where background ion detection may impair measurement. Therefore, clear separation and unique fragmentation patterns are necessary for accurate steroid hormone measurement.

Most studies feature methods aimed at monitoring single hormones or specific hormone classes (e.g. estrogens or androgens) within a given sample analysis [1117]. Estrogens present an additional complication for multi-class methods in that endogenous circulating concentrations in serum are typically in the low pg/mL range. In addition, estrogens are relatively polar in comparison to many of the other steroid classes making fragmentation of these compounds in electrospray suboptimal. Therefore, estrogens are often not included in the existing multi-class LC-MS/MS methods for serum. To our knowledge, few publications describe a method using LC-MS/MS detection of all four classes in serum [18, 10, 19] and those that claim this ability lack sensitivity for biologically relevant concentrations of multiple estrogens or contains proprietary information which requires the purchase of a commercial kit to conduct the analysis. There exists a need within the hormone measurement community for an improved measurement method for the multi-class detection of steroid hormones capable of highly sensitive and specific measurements in biological matrices using LC-MS/MS.

This manuscript outlines a method that allows for multi-class analysis using a single extraction and chromatographic method with high specificity for steroid hormones and hormone-like structures validated through the use of standard reference materials (SRMs) from the National Institute of Standards and Technology (NIST). The aims of this research were four-fold: 1) develop an LC-MS/MS method to measure biologically relevant ranges of multiple steroid hormone standards (from four steroid classes previously mentioned) in a single method using only unique fragmentation patterns (i.e. not monitoring the loss of water); 2) test the feasibility of this approach in detecting various concentrations of steroid hormones in a high-background hormone-stripped, fetal bovine serum (FBS) extract; 3) determine the enhancement of estrogen detection in both matrices through dansyl chloride (DC) derivatization without the need to change chromatographic parameters; 4) compare values derived from this method to certified concentrations of hormones from serum and plasma SRMs.

Materials and Methods

Materials

For the purpose of method development, a focus was placed on examining steroid hormones either with known biological action or present at critical points in steroid synthesis pathways (Figure 1). Neat sources of adrenosterone (AT), androstenedione (AE), dehydroepiandrosterone (DHEA), dihydrotestosterone (DHT), testosterone (T), estradiol (E2), estrone (E1), estriol (E3), equilin (EQ), progesterone (P4), pregnenolone (P5), 17-hydroxyprogesterone (17-OHP4), 17-hydroxypregnenolone (17-OHP5), cortisol (F), corticosterone (B), 11-deoxycorticosterone (DOC), and 11-deoxycortisol (S) were obtained for this study (manufacturer information in Online Resource 1). The structural diversity of these compounds includes 18 to 21 carbon structures, aromatic and non-aromatic A rings, A or B ring double bonds, zero to three carybonyl groups, and zero to three hydroxyl groups. EQ is unique to the classes as it is an equine estrogen that is widely used as a pharmaceutical during estrogen replacement therapy for postmenopausal women [20]. While not physiologically relevant to humans, EQ was incorporated to further explore the flexibility in analyzing non-human steroid-like structures. EQ is an excellent surrogate because it is not synthesized through the cholesterol pathway [21], is structurally different from most human steroids (18 carbons with an aromatic A ring and an additional double bond in the B ring), and informs the future use of this technique in the investigation of both wildlife endocrinology and pharmaceutical detection.

Internal standards (IS) representative of the major hormones, testosterone-13C3 (T-13 C3), estradiol-13C3 (E2-13C3), progesterone-13C2 (P4-13C2), pregnenolone-13C2d2 (P5-13C2d2), 17-hydroxyprogesterone-13C3 (17-OHP4-13C3), and cortisol-d4 (F-d4), were used to assist in quantification of the hormones (see manufacturer details in Online Resource 1). A single mixture of all IS (300 ng/mL of each) was prepared. From this mixture, 250 µL was added gravimetrically to samples and calibrants yielding 75 ng of each IS. A new carbon labeled P4 (a 13C3 labeled IS as opposed to the 13C2 used in the previous sections) became available during these analyses and was adopted for the SRM measurement portion of this study.

LC-MS/MS Method Optimization

All steroids were optimized on an AB Sciex API4000 QTRAP (Framingham, MA) hybrid triple quadrupole/linear ion trap mass spectrometer equipped with electrospray ionization (ESI, positive mode) in tuning mode. Individual steroids were directly injected and fragmentation patterns were evaluated at varying collision energies until two to four candidate product ions were identified and one product ion selected based on both compound and source specific parameter optimization (Table 1). A fragmentation pattern of a loss of 18 or 36 mass units was excluded as these were most likely a loss of water molecules. Instrument parameters were compared across all optimized fragmentation patterns and selected based on no major loss in detection for any compound analyzed (curtain gas = 207 kPa, temperature = 700° C, ion source gas 1 = 310 kPa, ion source gas 2 = 414 kPa, interface heater = On, collision gas = medium, and ion spray voltage = 5500 V).

Table 1.

Parameters for steroid analysis using liquid chromatography tandem 522 mass spectrometry.

Steroid Common Name Abbreviations Absolute
Mass
(m/z)
Ion/Reaction Precursor
Ion (m/z)
Product
Ion
(m/z)
DP
(V)
EP
(V)
CE
(V)
CXP
(V)
Retention
Time
(min)
Androgens

Adrenosterone AT 300.4 [M+H]+ 301.0 121.2 75 10 30 10 14.81
Androstenedione AE 286.4 [M+H]+ 287.2 97.2 100 15 30 12 17.33
Androstenedione-13C3 AE-13C3 289.4 [M+H]+ 290.6 100.2 75 10 40 5 17.33
Dehydroepiandrosterone DHEA 288.4 [M+H-
2H2O]+
253.3 197.3 75 10 25 10 11.21
Dihydrotestosterone DHT 290.4 [M+H]+ 291.3 255.4 75 10 25 10 13.62
Testosterone T 288.4 [M+H]+ 289.1 97.2 100 15 30 12 14.11
Testosterone-13C3 T-13C3 291.6 [M+H]+ 292.6 112.2 75 10 40 5 14.08

Estrogens

Equilin EQ 268.4 [M+H]+ 269.2 211.2 75 10 25 10 12.83
Estradiol E2 272.4 [M+H-
H2O]+
255.3 159.2 75 10 25 10 10.91
Estradiol-13C3 E2-13C3 275.4 [M+H-
H2O]+
258.2 162.2 50 10 35 10 10.91
Estriol E3 288.4 [M+H-
H2O]+
271.3 133.4 75 10 25 10 10.01
Estrone E1 270.4 [M+H]+ 271.1 159.3 75 10 30 10 12.84

Progestogens

17-Hydroxypregnenolone 17-OH-P5 332.5 [M+H-
H2O]+
315.4 297.3 40 5 20 5 10.97
17-Hydroxyprogesterone 17-OH-P4 330.4 [M+H]+ 331.2 97.2 75 10 25 10 13.85
17-Hydroxyprogesterone-
13C3
17-OH-P4-13C3 333.4 [M+H]+ 334.6 100.1 40 5 40 5 13.88
Pregnenolone P5 316.5 [M+H-
H2O]+
299.4 161.4 75 15 25 10 13.37
Pregnenolone-13C2-d2 P5-13C2-d2 320.5 [M+H-
H2O]+
303.6 161.3 40 5 40 10 13.36
Progesterone P4 314.5 [M+H]+ 315.1 97.2 75 15 25 10 19.21
Progesterone-13C2 P4-13C2 316.5 [M+H]+ 317.6 99.1 75 10 45 15 19.18
Progesterone-13C3 P4-13C3 317.5 [M+H]+ 318.4 112.2 50 10 35 5 19.18

Corticosteroids

11-Deoxycorticosterone DOC 330.5 [M+H]+ 331.7 109.3 75 10 35 5 17.10
11-Deoxycortisol S 346.5 [M+H]+ 347.3 97.1 75 15 30 10 12.97
Corticosterone B 346.5 [M+H]+ 347.2 121.3 40 5 20 15 13.18
Cortisol F 362.5 [M+H]+ 363.1 121.1 75 10 25 10 11.36
Cortisol-d4 F-d4 366.5 [M+H]+ 367.4 121.3 75 10 25 10 11.32

Dansyl Chloride Derivatized Estrogens

Dansyl Chloride Equilin DC-EQ 268.4 Mono-DC 502.4 171.5 75 10 35 10 24.76
Dansyl Chloride Estradiol DC-E2 272.4 Mono-DC 506.4 171.5 125 5 35 15 19.42
Dansyl Chloride
Estradiol-13C3
DC-E2-13C3 275.4 Mono-DC 509.3 171.3 75 10 40 15 19.40
Dansyl Chloride Estriol DC-E3 288.4 Mono-DC 522.3 171.3 125 10 35 15 15.48
Dansyl Chloride Estrone DC-E1 270.4 Mono-DC 504.3 171.2 125 5 35 15 25.92

A novel separation method was developed using a Restek Ultra Biphenyl column (250 mm × 4.6 mm, 5.0 µm particle size) heated at 35 °C on an Agilent 1200 Series HPLC system equipped with a binary pump and autosampler was used to separate steroid hormones. Sample injection volume was 5 µL and flow was 300 µL/min. Total LC analysis time was 40 min with a solvent gradient consisting of MeOH and acetonitrile (ACN), both containing 0.1 % formic acid. The gradient was as follows: MeOH 80 % to 55 % for 30 min, 55 % to 20 % for 1 min and held for 4 min, up to 80 % in 0.1 min, and held at 80 % for the remaining 9.9 min. Retention times for each compound were determined using multiple-reaction monitoring (MRM) (Figure 1). After optimization, measurements of all steroids and IS were monitored using scheduled multiple-reaction monitoring (sMRM).

Calibration and Limit of Detection

Initial quantitation experiments were conducted using standards of 17 endogenous steroid hormones prepared in MeOH at ten calibration levels in borosilicate glass culture tubes (n = 3 for each level). The 17 steroids were combined and used to prepare a ten point calibration curve ranging from 6 pg to 500 ng in methanol. Approximately 250 µL of IS mixture was gravimetrically added to each sample. These calibration standards were evaporated under a gentle stream of high-purity nitrogen and reconstituted in 200 µL of MeOH prior to analysis by LC-MS/MS. Sample analysis position was randomized along with two types of blanks, solvent blanks containing only MeOH and IS blanks containing only internal standards in MeOH. IS blanks were analyzed to obtain limits of detection (LOD) in the absence of matrix.

LODs were also determined in a charcoal stripped FBS in order to simulate an actual blood sample. Briefly, 2 mL of activated-charcoal stripped FBS (Invitrogen) was combined with 8 mL of cold MeOH to precipitate proteins. Aliquots were vortexed for 1 min and allowed to settle for 3 min before being frozen at −80 °C for 3 min. The supernatant was then pooled. FBS extract equivalent to 1 mL of whole FBS was then aliquoted into culture tubes and amended with calibration standards and IS as above (n = 5 for each level). Samples were then evaporated to dryness under nitrogen, reconstituted in 200 µL of MeOH, and transferred to autosampler vial inserts. FBS blanks were made by adding FBS extract and 500 µL of MeOH to replace the calibration standard and IS solutions. FBS IS blanks contained FBS extract, 75 ng of IS and 250 µL of MeOH to replace the calibration standard.

Dansyl Chloride Derivatization

To aid in the detection of estrogens, a derivatization method (dansylation) was examined and the results were compared to those obtained from the underivatized estrogens. DC dertivatization was conducted for estrogens amended to methanol (three samples per level) and FBS (five samples per level).

The DC protocol was conducted according to Nelson et al. [6]. The dansylated sample was evaporated under nitrogen at 40 °C, reconstituted in 200 µL MeOH, vortexed for 10 s and transferred (avoiding any undissolved salts) to a 250 µL glass autosampler vial insert. Optimization of MS/MS fragmentation patterns and conditions were conducted for all DC-derivatized compounds using the same instrument parameters and chromatographic conditions the underivatized compounds.

Standard Reference Material (SRM) Measurement

This analysis was conducted on SRMs 971M and 971F, Hormones in Human Serum (male and female), and SRM 1950, Metabolites in Human Plasma. SRMs 971 and 1950 are certified for F, T, and P4 and provide analysis of both a serum and plasma matrix. All SRMs were measured for AT, AE, DHEA, DHT, T, E2, E1, E3, P4, P5, 17-OHP4, 17-OHP5, F, B, DOC, and S as well.

Sample extraction was performed using a modified solid phase extraction (SPE) outlined by Tai et al. and Budzinksi et al.[22, 13, 23] An internal standard (IS) mixture in methanol (MeOH) was added volumetrically (500 µL) to borosilicate glass culture tubes using airtight gas syringes and tracked gravimetrically. The IS mixture was then reduced to dryness under nitrogen before the addition of matrix to prevent precipitation of proteins in the serum and plasma. Serum (2 mL; n = 5), plasma (2 mL; n = 5), calibration standards, or MilliQ water for blanks were gravimetrically added into borosilicate culture tubes. Blanks were analyzed in triplicate and contained only the IS mixture that was reconstituted with MilliQ water. Sodium acetate buffer (4 mL, 0.01 M, pH 5) was added to the tubes, lightly vortexed, and then allowed to incubate at room temperature for 1 h. Supelclean LC-18 SPE cartridges (1 g × 6 mL) (Sigma, Bellefonte, PA) were used for extraction. Columns were conditioned with 5 mL methanol (MeOH), followed by 5 mL MilliQ water, and 1 mL acetate buffer (0.01 M, pH 5). Sample was then loaded after the incubation period and washed with 12 mL of MilliQ water followed by 5 mL of a solution of 80:20 MilliQ water and acetonitrile. The sample was then eluted into a clean borosilicate culture tube with 2.5 mL of MeOH. The eluate was then evaporated to dryness on nitrogen at 40 °C, reconstituted in 200 µL of MeOH, vortexed for 10 s and transferred to a 250 µL glass autosampler vial insert in an amber autosampler vial.

For the analysis of estrogens, a dansyl chloride (DC) derivatization was conducted after LC-MS/MS measurement of the other steroid classes. An aliquot of 100 µL of extract was removed from the autosampler and added to a borosilicate culture tube for reaction. Derivatized samples were then reconstituted in 100 µL of methanol, vortexed for 10 s and transferred to a 250 µL glass autosampler vial insert in an amber autosampler vial.

Quantitation

Integrations were conducted using Analyst v1.5.2 (AB Sciex). Data analyses were conducted using appropriate IS adjusted peak areas and masses (see Table 2 for steroid/IS pairing). A linear regression (y = mx + b) was performed on the range of the calibration standards that not only gave linearity (R2 ≥ 0.9996) but also represented the biologically significant reference range of the steroid in humans [24, 25].

Table 2.

Limit of detection (LOD) and limit of quantitation (LOQ) for steroids measured in methanol, fetal bovine serum (FBS), and standards reference materials (SRMs). Statistical (st) and empirical (em) LODs were calculated and the highest value taken for the SRMs. Values are presented in total ng in the measured extract which was 2 mL of material.

Steroid Internal
Standard
Methanol FBS SRMs

LODst LODem LODst LODem LOQ
11-Deoxycorticosterone F-d4 0.35 0.8 1.25 2 0.024
11-Deoxycortisol F-d4 0.29 0.8 1 2 3.05
17-OH-Pregnenolone 17-OH-P4-13C3 0.23 0.8 0.68 0.16 c ND
17-OH-Progesterone 17-OH-P4-13C3 a - 0.16 1.01 2 0.146
Adrenosterone AE-13C3 0.051 0.06 0.94 2 1.92
Androstenedione AE-13C3 0.12 0.06 1.05 2 0.0541
Corticosterone F-d4 - 0.16 b NA >500 1.34
Cortisol F-d4 - 0.06 0.31 0.8 121
DC-Equilin DC-E2-13C3 0.36 0.16 0.043 0.8 ND
DC-Estradiol DC-E2-13C3 0.032 0.16 0.4 0.8 0.0156
DC-Estriol DC-E2-13C3 0.095 0.16 0.42 0.8 0.0197
DC-Estrone DC-E2-13C3 - 0.16 0.23 0.8 0.000570
DHEA T -13C3 NA >500 NA 4 ND
DHT T -13C3 NA 10 NA 10 ND
Equilin E2-13C3 0.58 0.8 1.35 2 ND
Estradiol E2-13C3 0.64 0.8 1.09 2 ND
Estriol E2-13C3 6.33 10 NA 100 ND
Estrone E2-13C3 0.90 0.8 - 2 ND
Prenenolone P5-13C2d2 0.26 0.8 0.66 0.8 ND
Progesterone P4-13C2 0.068 0.16 1.23 2 0.0894
Testosterone T-13C3 - 0.06 0.8 2 0.140
a

(−) negative value

b

(NA) Could not be calculated

c

(ND) Not detected

The LODs were calculated using two approaches, statistical and empirical [26]. First, the sample noise was selected from the IS blanks containing only internal standard. Next, a linear regression was generated from the calibration curve and a statistical LOD (LODst) was extrapolated from the equation using:

LODst=(mean noise area+(3*standard deviation of the noise)b)×ISmm

Where b = the intercept, m = the slope, and ISm = the appropriate internal standard mass. The LODst was selected if the model’s R2 ≥ 0.9998. Secondly, the empirical LOD (LODem) was based on the lowest calibration standard successfully measured which was greater than three times the standard deviation of the noise plus the mean noise area.

Response factors were calculated to determine the efficacy of the derivatization on the detection of estrogens using DC in comparison to the detection with no derivatization. T-13C3 internal standard was used as a surrogate internal standard because unlike the estrogen internal standards, the T-13C3 did not derivatize and had a constant response between the two analyses. Linear regressions were determined for the ratio of peak area of the estrogen and peak area of T-13C3 by the ratio of the mass of the estrogen by the mass of T-13C3 in the sample. The slope of this linear regression was defined as the response factor.

After screening of the SRMs, three calibration mixtures were produced containing E2, E3, E1, S, B, 17-OH-P4, T, DOC, AE, AT, and P4. Because F concentrations were an order of magnitude greater than the other steroids analyzed, a separate calibration curve was constructed containing only F. For accuracy, T was measured on two ends of the calibration curves as the concentrations for 971F were in the pg/mL range while the other materials were in the ng/mL range. For increased accuracy, all calibration solutions were spiked with the IS mixture and treated identically to samples during the extraction process. Masses of each analyte were calculated using the linear or quadratic regression of at least a three point calibration curve that bracketed the sample peak area ratios (area of the analyte over area of the appropriate internal standard). Concentrations were determined by dividing the calculated mass of each analyte by the extracted sample mass. Again, the LOD was determined as the lowest calibration standard or three times the standard deviation plus the mean of the internal standard blanks for each analyte, and the highest value was denoted as the limit of quantitation (LOQ) [26]. Percent differences were calculated using the mean measured value and the certified values which do not take in to account the range of uncertainty; however, given the small ranges of uncertainty on the certified values, percent differences were included for comparison.

Results and Discussion

Chromatographic separation of 17 endogenous hormones and seven internal standards was achieved a using unique solvent and stationary phase combination (Figure 2). Most publications of steroid hormone analysis focus on certain hormones or classes of hormones chromatographically separated with a methanol:water solvent phase and use C18 columns [17]. We found that using a biphenyl column with a methanol:acetonitrile mobile phase yielded better separation by capitalizing on the difference in affinities for acetonitrile by the number of carbonyls versus hydroxyl groups of the highly structurally similar steroids. Many steroids including T and DHEA (289 amu), 17-OH-P4 and DOC (331 amu), P4 and 17-OH-P5 (315 amu), and B and S (347 amu) have the same precursor ion mass and generate similar fragments (121 and 97 are common steroid fragments). These compounds were clearly separated by elution time, thereby reducing errors in quantification. The use of these solvents instead of water helped maintain excellent peak resolution, and potentially reduces laboratory variability generated by the source of water.

Fig. 2.

Fig. 2

Chromatograms for separation of steroid hormones at 100 ng calibration standard concentration. (a) Underivatized. (b) Dansyl chloride derivatized. 1. Estriol (E3), 2. Estradiol-13C3 (E2-13C3), 3. Estradiol (E2), 4. 17-OH-Pregnenolone (17-OH-P5), 5. Dehydroepiandrosterone (DHEA), 6. Cortisol (F), 7. Cortisol- d4 (F-d4), 8. Equilin (EQ), 9. Estrone (E1), 10. 11-Deoxycortisol (S), 11. Pregnenolone-13C2d2 (P5-13C2d2), 12. Pregnenolone (P5), 13. Dihydrotestosterone (DHT), 14. 17-OH-Progesterone (17-OH-P4), 15. 17-OH-Progesterone-13C3 (17-OH-P4-13C3), 16. Corticosterone (B), 17. Testosterone (T), 18. Testosterone-13C3, (T-13C3), 19. Adrenosterone (AT), 20. 11-Deoxycorticosterone (DOC), 21. Androstenedione (AE), 22. Androstenedione-13C3 (AE-13C3), 23. Progesterone (P4), 24. Progesterone-13C2 (P4-13C2), 25. DC-Estriol (DC-E3), 26. DC-Estradiol (DC-E2), 27. DC-Estradiol-13C3,(DC-E2-13C3), 28. DC-Equilin (DC-EQ), 29. DC-Estrone (DC-E1).

Calibration curves with concentrations over physiologically relevant ranges were constructed successfully for all but two hormones (Online Resource 2). DHEA and DHT were not detectable within biological ranges using this methodology; therefore, LODs could not be calculated (Table 2). DHEA is a biologically important androgen; however, measurements of DHEA-sulfate (DHEA-S), which circulates at higher concentrations in the blood, is more stable than DHEA in the blood and is often used as a proxy for DHEA [27]. Chromatography and MS/MS fragmentation would have to be explored further to add DHEA-S to this method. DHT is a highly important androgen for development, but most of the enzymatic activity to produce DHT from T occurs within target tissues, such as the skin and prostate [28]. Because DHT is synthesized and acts locally, serum DHT measurements may not be an informative measurement, and could be excluded from this method in the future.

Detection of most of the selected steroids did not appear to be compromised by the use of an FBS matrix (Table 2). Among the underivatized compounds, B was the only steroid that could be quantified only in MeOH and not in FBS. This was because the LOD for B in FBS was above all except the highest calibration standard (500 ng/mL) possibly indicating residual B in FBS. Additionally, the slope for FBS detection was greatly increased in FBS (57.625 in methanol to 106.86 in FBS; Supplementary Tables 2 and 3) indicating a potential matrix interference or more likely residual DOC in the bovine serum as this is the precursor hormone to the production of B. However, the LOD for B in MeOH was considerably lower (0.16 ng/mL). In humans, B is found in low concentrations (approximately 7 ng/mL), but B is a major hormone in many other species including bovines (approximately 30 µg/mL) [29, 30]. In non-human species, the calibration curve should be adjusted to higher concentrations, but given the performance of B and DOC detection in the higher ranges of the MeOH samples, this should not be an issue.

The developed method was able to circumvent the issues of low biological concentrations and poor ionization and fragmentation of estrogens by using a DC derivatization on the same extract under the same chromatographic and instrument conditions as the underivatized method, limiting the amount of labor to add these compounds to the analysis. DC derivatization performed well in enhancing detection of all measured estrogens. The response curves were greatly enhanced (two- to eight-fold) for estrogens with DC derivatization (Figure 3). Additional benefits to DC-derivatization were also exhibited, which included improved chromatography. Underivatized EQ and E1 (a difference of two mass units) showed poor separation with current LC method; however, after DC derivatization, complete separation of EQ and E1 was achieved (Figure. 2). Further, the LODs of E3 and E1 could not be calculated in the FBS matrix without DC derivatization. After derivatization, E1 had an LOD of 200 pg/mL and E3 an LOD of 400 pg/mL. An additional benefit to E1 derivatization was that potential interferences in the measurement of underivatized E1 in FBS (change in slope from 41.539 in methanol to 79.088 in FBS) were eliminated through derivatization (slopes equal 24.790 and 28.771 in methanol and FBS respectively; Supplemental Tables 2 and 3).

Fig. 3.

Fig. 3

Dansyl chloride derivatization response factors. Underivatized estrogens are in black. Dansyl chloride derived estrogens are in grey. Response factors in methanol (a) and fetal bovine serum (b).

The purpose of using an extracted FBS was to examine the efficacy of the method in a high background non-human sample. Specialized extractions for steroid hormones, rather than a non-specific protein precipitation, would greatly enhance detection capabilities. Therefore, we continued with an analysis of human serum and plasma SRMs cleaned by SPE. LODs were greatly improved through the use of a simple SPE clean-up procedure compared to the FBS matrix (Table 2). Additionally, inclusion of calibration standards of lower concentrations than previously analyzed in the experiments lowered the LOD for some compounds (DOC, AE, E2, E3, E1, 17-OH-P4; see Online Resources 2 to 4 for calibration curve information). Analysis of F, T, and P4 had good agreement (percent differences of less than 8.5 %, 13.3 %, and 2.85 % respectively) with SRM certified values for human male and female serum (SRMs 971M and 971F) as well as for human plasma (SRM 1950; Figure 4 and Table 3) indicating the accuracy of this single method compared to the three separate methods used to certify the SRMs.

Fig. 4.

Fig. 4

Measured and certified concentrations of cortisol, testosterone, and progesterone for three standard reference materials (SRMs), SRM 1950 (human plasma), SRM 971M (human male serum), and SRM 971F (human female serum). Error bars are one standard deviation for measured values and 95% expanded uncertainty for certified values. Numbers above brackets are the percent difference between the measured and certified values.

Table 3.

Means and statistics for steroid hormone measurements in standard reference materials (SRMs). Extractions were performed on 2 mL of sample but values presented are mass adjusted to ng/g.

SRM 1950
Plasma
SRM 971 M
Male Serum
SRM 971 F
Female Serum

Steroid Mean
(ng/g)
Stdev RSD Certified
value
(ng/g)
Mean
(ng/g)
Stdev RSD Certified
value
(ng/g)
Mean
(ng/g)
Stdev RSD Certified
value
(ng/g)
DOC 0.0281 0.0069 24.5 % 0.0611 0.0410 67.1 % 0.0989 0.0599 60.6 %
S 10.1 2.4 23.5 % 6.92 1.66 24.0 % 3.46 0.97 28.2 %
17-OH-P4 1.19 0.06 4.88 % 1.80 0.05 2.77 % 1.26 0.20 16.2 %
AT 0.398 0.040 10.1 % 0.365 0.020 5.38 % 0.252 0.042 16.9 %
AE 0.817 0.008 1.03 % 0.543 0.015 2.82 % 0.658 0.034 5.11 %
B 1.61 0.32 19.8 % 3.81 0.47 12.3 % 2.07 0.63 30.5 %
F 93.9 6.05 6.44 % 82.2 ±
a1.7
98.9 6.3 6.33 % 105.0 ±
1.5
80.7 9.2 11.4 % 88.5 ±
2.1
DC-E2 0.0460 0.0029 6.28 % a -
<LOD
<LOD- <LOD- 0.0881 0.0145 16.4 %
DC-E3 0.166 0.037 22.0 % 0.142 0.031 22.1 % 0.255 0.080 31.2 %
DC-E1 0.0394 0.0061 15.6 % 0.0310 0.0027 8.79 % 0.0723 0.0088 12.2 %
P4 1.44 0.01 0.595
%
1.452 ±
0.037
0.0403 0.0013 3.25 % 0.0403 ±
0.0062
1.96 0.13 6.60 % 1.903 ±
0.068
T 2.35 0.02 0.828
%
2.169 ±
0.046
5.89 0.33 5.63 % 6.279 ±
0.143
0.295 0.040 13.4 % 0.271 ±
0.006
a

number following ± is the uncertainty

Only three of the 13 final compounds analyzed in the SRMs were not reliably quantifiable (Table 3). These were DOC, S, and E3, which were present, but were more variable RSD > 20%). Quantification of E3 lacked precision most likely because of the low concentrations in the samples tested. Most of the estrogens remain in the low pg/mL ranges except leading up to ovulation (E2) or during pregnancy (E3) [31, 24]. Therefore, this method could be used to examine pregnancy in humans and wildlife when E3 concentrations are elevated. Additionally, B quantification lacked precision for SRM 1950 and 971F, again most likely from being at the lower limits of quantification in these materials, because quantification was possible at higher concentrations in SRM 971M.

Estrogens were quantified in all three matrices. E2 concentrations were too low to detect in the pooled male sample, SRM 971M, with this method. However, one note about the measurement of these SRMs is that these are pooled samples that have potentially incurred one freeze-thaw cycle in preparation. Degradation of some hormones that undergo freeze-thaw is expected, particularly E2 and E1 which have been shown to decrease in concentration with each freeze-thaw cycle [32]. Therefore, the concentrations reported here are lower than would be expected and E2 concentrations in men may still be measurable in samples that have only been frozen once before analysis.

A horse estrogen, EQ, used as a pharmaceutical, was separated and measured displaying the method’s utility for additional analytes including steroid hormones found in other vertebrate species. Future analyses have the potential to include11-keto-testosterone from fish or synthetic steroids of similar structure such as ethinyl estradiol as demonstrated by the quantification of disparate but similar steroid structures. From compounds with three carbonyl (AT) to three hydroxyl (E3) groups, this method demonstrated an enhanced capability in detecting a wide range of steroid hormones that has the potential to be used for human and wildlife endocrinology as well as pharmaceutical analysis.

This method allows for the accurate and precise measurement of T, P4, and F in a single method. The measured hormones had RSDs under 14 % and a percent differences with certified values on both human male and female serum (SRM 971) matrix as well as a human plasma (SRM 1950) matrix of less than 12 %. Additionally, it provided precise measurement of E2, E1, 17-OH-P4, AE, and AT, but measurements of S and B are more variable and dependent on concentrations of the hormones in the material. The method did not measure E3 or DOC concentrations well, presumably due to low concentrations in the materials. Further testing of these hormones in other samples such as pregnant (E3) or stressed (DOC, S, and B) individuals may increase concentrations of these hormones to quantifiable concentrations.

This method was flexible in its ability to detect multiple classes of steroid hormones with relatively minimal clean-up and is a promising method for the measurement of biologically relevant concentrations of hormones. We have shown this method to be effective in the direct measurement of several steroids from different classes, including the difficult to quantify estrogens, using a single methodology. Additionally, the method successfully quantified certified concentrations of T, F, and P4 in three SRMs (male serum, female serum, and plasma matrices) using only one method as opposed to the previously required three separate methods. The chromatographic separation using the MeOH:ACN gradient on a biphenyl column, in combination with sMRM monitoring of steroid specific fragmentation patterns, allowed for separation and accuracy in peak measurement, which is essential for comprehensive steroid profiling. In the future we intend to explore a reduction in the amount of material needed for analysis. However, given the number of hormones measured in this method, the 2 mL currently required is not excessive. Additionally, this extraction method has the capability to be fully automated with SPE automation technology currently on the market, which would further reduce manpower and time to complete analysis.

The utility of this method is far reaching in its ability to measure endpoints from hormone pathways in a single sample as opposed to the one-at-a-time approach of immunoassays which becomes particularly useful when multiple samples are difficult or costly to collect and store. Using this method, a single frozen aliquot of serum or plasma yielded the same information as 11 to 12 individual immunoassays, saving time and labor. By measuring suites of hormones instead of a few carefully selected hormones, knowledge of complex biological events can be increased, which in turn aids in diagnosis of endocrine disruption of development, reproduction, and behavior.

Supplementary Material

Supp1

Acknowledgments

For partial funding, we acknowledge the National Oceanographic and Atmospheric Administration (NOAA) and the Smart State Center of Economic Excellence for Marine Genomics. We extend thanks to Lori Schwacke of NOAA for being the impetus to develop this method. Also, we thank Kevin Huncik for performing instrument maintenance and troubleshooting assistance. Finally we would like to thank the NIST/National Research Council postdoctoral program for financial support during this research.

Footnotes

Conflict of Interest

The authors declare that they have no conflict of interest.

Disclaimer

Certain commercial equipment, instruments, or materials are identified in this paper to specify adequately the experimental procedure. Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose.

References

  • 1.Norris DO. Vertebrate Endocrinology. 4. Burlington, MA: Elsevier Inc.; 2007. [Google Scholar]
  • 2.Hanukoglu I. Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis. J Steroid Biochem Mol Biol. 1992;43(8):779–804. doi: 10.1016/0960-0760(92)90307-5. [DOI] [PubMed] [Google Scholar]
  • 3.Miller WL. Molecular Biology of Steroid Hormone Synthesis. Endocr Rev. 1988;9(3):295–318. doi: 10.1210/edrv-9-3-295. doi: [DOI] [PubMed] [Google Scholar]
  • 4.Falkenstein E, Tillmann H-C, Christ M, Feuring M, Wehling M. Multiple Actions of Steroid Hormones—A Focus on Rapid, Nongenomic Effects. Pharmacol Rev. 2000;52(4):513–556. [PubMed] [Google Scholar]
  • 5.Hodges JK, Vanaarde RJ, Heistermann M, Hoppen HO. Progestin content and biosynthetic potential of the corpus-luteum of the African elephant (Loxodontia africana) J Reprod Fertil. 1994;102(1):163–168. doi: 10.1530/jrf.0.1020163. [DOI] [PubMed] [Google Scholar]
  • 6.Nelson RE, Grebe SK, O'Kane DJ, Singh RJ. Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Measurement of Estradiol and Estrone in Human Plasma. Clin Chem. 2004;50(2):373–384. doi: 10.1373/clinchem.2003.025478. [DOI] [PubMed] [Google Scholar]
  • 7.Taieb J, Mathian B, Millot F, Patricot M-C, Mathieu E, Queyrel N, et al. Testosterone Measured by 10 Immunoassays and by Isotope-Dilution Gas Chromatography–Mass Spectrometry in Sera from 116 Men, Women, and Children. Clin Chem. 2003;49(8):1381–1395. doi: 10.1373/49.8.1381. [DOI] [PubMed] [Google Scholar]
  • 8.Bock JL. The new era of automated immunoassay. Am J Clin Pathol. 2000;113(5):628–646. doi: 10.1309/DUDM-3Y6L-3R1L-QP15. [DOI] [PubMed] [Google Scholar]
  • 9.Hansen M, Jacobsen NW, Nielsen FK, Bjorklund E, Styrishave B, Halling-Sorensen B. Determination of steroid hormones in blood by GC-MS/MS. Anal Bioanal Chem. 2011;400(10):3409–3417. doi: 10.1007/s00216-011-5038-8. [DOI] [PubMed] [Google Scholar]
  • 10.Koal T, Schmiederer D, Pham-Tuan H, Röhring C, Rauh M. Standardized LC–MS/MS based steroid hormone profile-analysis. J Steroid Biochem Mol Biol. 2012;129(3–5):129–138. doi: 10.1016/j.jsbmb.2011.12.001. doi: http://dx.doi.org/10.1016/j.jsbmb.2011.12.001. [DOI] [PubMed] [Google Scholar]
  • 11.Tai SSC, Welsh MJ. Development and evaluation of a reference measurement procedure for the determination of estradiol-17 beta in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem. 2005;77(19):6359–6363. doi: 10.1021/ac050837i. [DOI] [PubMed] [Google Scholar]
  • 12.Tai SSC, Xu B, Welch MJ. Development and evaluation of a candidate reference measurement procedure for the determination of progesterone in human serum using isotope-dilution liquid chromatography/tandem mass spectrometry. Anal Chem. 2006;78(18):6628–6633. doi: 10.1021/ac060936b. [DOI] [PubMed] [Google Scholar]
  • 13.Tai SSC, Xu B, Welch MJ, Phinney KW. Development and evaluation of a candidate reference measurement procedure for the determination of testosterone in human serum using isotope dilution liquid chromatography/tandem mass spectrometry. Anal Bioanal Chem. 2007;388(5–6):1087–1094. doi: 10.1007/s00216-007-1355-3. [DOI] [PubMed] [Google Scholar]
  • 14.Carvalho VM, Nakamura OH, Vieira JG. Simultaneous quantitation of seven endogenous C-21 adrenal steroids by liquid chromatography tandem mass spectrometry in human serum. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;872(1–2):154–161. doi: 10.1016/j.jchromb.2008.07.035. [DOI] [PubMed] [Google Scholar]
  • 15.Etter ML, Eichhorst J, Lehotay DC. Clinical determination of 17-hydroxyprogesterone in serum by LC-MS/MS: comparison to Coat-A-Count RIA method. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;840(1):69–74. doi: 10.1016/j.jchromb.2006.04.038. [DOI] [PubMed] [Google Scholar]
  • 16.Kulle AE, Riepe FG, Melchior D, Hiort O, Holterhus PM. A novel ultrapressure liquid chromatography tandem mass spectrometry method for the simultaneous determination of androstenedione, testosterone, and dihydrotestosterone in pediatric blood samples: age- and sex-specific reference data. J Clin Endocrinol Metab. 2010;95(5):2399–2409. doi: 10.1210/jc.2009-1670. [DOI] [PubMed] [Google Scholar]
  • 17.Abdel-Khalik J, Björklund E, Hansen M. Development of a solid phase extraction method for the simultaneous determination of steroid hormones in H295R cell line using liquid chromatography–tandem mass spectrometry. J Chromatogr B. 2013;935(0):61–69. doi: 10.1016/j.jchromb.2013.07.013. doi: http://dx.doi.org/10.1016/j.jchromb.2013.07.013. [DOI] [PubMed] [Google Scholar]
  • 18.Ceglarek U, Kortz L, Leichtle A, Fiedler GM, Kratzsch J, Thiery J. Rapid quantification of steroid patterns in human serum by on-line solid phase extraction combined with liquid chromatography-triple quadrupole linear ion trap mass spectrometry. Clin Chim Acta. 2009;401(1–2):114–118. doi: 10.1016/j.cca.2008.11.022. [DOI] [PubMed] [Google Scholar]
  • 19.Guo T, Taylor RL, Singh RJ, Soldin SJ. Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta. 2006;372(1–2):76–82. doi: 10.1016/j.cca.2006.03.034. [DOI] [PubMed] [Google Scholar]
  • 20.Morgan MRA, Whittaker PG, Fuller BP, Dean PDG. A radioimmunoassay for equilin in post-menopausal plasma: Plasma levels of equilin determined after oral administration of conjugated equine oestrogens (Premarin) J Steroid Biochem. 1980;13(5):551–555. doi: 10.1016/0022-4731(80)90212-5. doi: http://dx.doi.org/10.1016/0022-4731(80)90212-5. [DOI] [PubMed] [Google Scholar]
  • 21.Numazawa M, Osawa Y. Equilin and equilenin biosynthesis. Stereochemistry of aromatization of 3-hydroxy-3,5,7-androstatrien-17-one by horse placenta. J Steroid Biochem. 1987;26(1):137–143. doi: 10.1016/0022-4731(87)90042-2. [DOI] [PubMed] [Google Scholar]
  • 22.Tai SS, Welch MJ. Development and evaluation of a candidate reference method for the determination of total cortisol in human serum using isotope dilution liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry. Anal Chem. 2004;76(4):1008–1014. doi: 10.1021/ac034966f. [DOI] [PubMed] [Google Scholar]
  • 23.Budzinski H, Devier MH, Labadie P, Togola A. Analysis of hormonal steroids in fish plasma and bile by coupling solid-phase extraction to GC/MS. Anal Bioanal Chem. 2006;386(5):1429–1439. doi: 10.1007/s00216-006-0686-9. [DOI] [PubMed] [Google Scholar]
  • 24.Kuijper EA, Ket JC, Caanen MR, Lambalk CB. Reproductive hormone concentrations in pregnancy and neonates: a systematic review. Reprod Biomed Online. 2013;27(1):33–63. doi: 10.1016/j.rbmo.2013.03.009. [DOI] [PubMed] [Google Scholar]
  • 25.Kushnir MM, Rockwood AL, Bergquist J. Liquid chromatography–tandem mass spectrometry applications in endocrinology. Mass Spectrom Rev. 2010;29(3):480–502. doi: 10.1002/mas.20264. [DOI] [PubMed] [Google Scholar]
  • 26.Ragland JM, Liebert D, Wirth E. Using procedural blanks to generate analyte-specific limits of detection for persistent organic pollutants based on GC-MS analysis. Anal Chem. 2014;86(15):7696–7704. doi: 10.1021/ac501615n. [DOI] [PubMed] [Google Scholar]
  • 27.Longcope C. Dehydroepiandrosterone metabolism. J Endocrinol. 1996;150(3 Suppl):S125–S127. [PubMed] [Google Scholar]
  • 28.Marchetti PM, Barth JH. Clinical biochemistry of dihydrotestosterone. Ann Clin Biochem. 2013;50(2):95–107. doi: 10.1258/acb.2012.012159. [DOI] [PubMed] [Google Scholar]
  • 29.Nishida S, Matsumura S, Horino M, Oyama H, Tenku A. A radioimmunoassay for human plasma corticosterone. Endocrinol Jpn. 1976;23(6):465–469. doi: 10.1507/endocrj1954.23.465. [DOI] [PubMed] [Google Scholar]
  • 30.Venkataseshu GK, Estergreen VL. Cortisol and Corticosterone in Bovine Plasma and the Effect of Adrenocorticotropin1,2. J Dairy Sci. 1970;53(4):480–483. doi: 10.3168/jds.S0022-0302(70)86234-8. [DOI] [PubMed] [Google Scholar]
  • 31.Buffet NC, Djakoure C, Maitre SC, Bouchard P. Regulation of the Human Menstrual Cycle. Front Neuroendocrinol. 1998;19(3):151–186. doi: 10.1006/frne.1998.0167. doi: http://dx.doi.org/10.1006/frne.1998.0167. [DOI] [PubMed] [Google Scholar]
  • 32.Comstock GW, Burke AE, Norkus EP, Gordon GB, Hoffman SC, Helzlsouer KJ. Effects of Repeated Freeze-Thaw Cycles on Concentrations of Cholesterol, Micronutrients, and Hormones in Human Plasma and Serum. Clin Chem. 2001;47(1):139–142. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp1

RESOURCES